152 related articles for article (PubMed ID: 34820809)
1. [Gastric MALT lymphoma - from pathogenetic insights to consequent deescalation of therapy].
Fischbach W
Z Gastroenterol; 2022 Apr; 60(4):602-612. PubMed ID: 34820809
[TBL] [Abstract][Full Text] [Related]
2. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis.
Al-Taie O; Al-Taie E; Fischbach W
Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277
[TBL] [Abstract][Full Text] [Related]
3. Patients with gastric MALT lymphoma revealing persisting endoscopic abnormalities after successful eradication of Helicobacter pylori can be safely managed by a watch-and-wait strategy.
Fischbach W; Dorlöchter C
Z Gastroenterol; 2019 May; 57(5):593-599. PubMed ID: 31083747
[TBL] [Abstract][Full Text] [Related]
4. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series.
Fischbach W; Goebeler ME; Ruskone-Fourmestraux A; Wündisch T; Neubauer A; Raderer M; Savio A;
Gut; 2007 Dec; 56(12):1685-7. PubMed ID: 17639089
[TBL] [Abstract][Full Text] [Related]
5. Gastric mucosal-associated lymphoid tissue lymphoma.
Fischbach W
Gastroenterol Clin North Am; 2013 Jun; 42(2):371-80. PubMed ID: 23639646
[TBL] [Abstract][Full Text] [Related]
6. Treatment Strategy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Nakamura S; Matsumoto T
Gastroenterol Clin North Am; 2015 Sep; 44(3):649-60. PubMed ID: 26314674
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
[TBL] [Abstract][Full Text] [Related]
8. Gastric MALT lymphoma - update on diagnosis and treatment.
Fischbach W
Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1069-77. PubMed ID: 25439072
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
11. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
Ferreri AJ; Govi S; Ponzoni M
Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of gastric lymphoma after stomach conserving treatment.
Fischbach W
Best Pract Res Clin Gastroenterol; 2010 Feb; 24(1):71-7. PubMed ID: 20206110
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori.
Nakamura S; Matsumoto T; Suekane H; Takeshita M; Hizawa K; Kawasaki M; Yao T; Tsuneyoshi M; Iida M; Fujishima M
Gut; 2001 Apr; 48(4):454-60. PubMed ID: 11247887
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori and gastric mucosa-associated lymphoid tissue lymphoma: recent progress in pathogenesis and management.
Nakamura S; Matsumoto T
World J Gastroenterol; 2013 Dec; 19(45):8181-7. PubMed ID: 24363507
[TBL] [Abstract][Full Text] [Related]
16. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.
Morgner A; Bayerdörffer E; Neubauer A; Stolte M
Gastroenterol Clin North Am; 2000 Sep; 29(3):593-607. PubMed ID: 11030075
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new.
Kuo SH; Cheng AL
Hematology Am Soc Hematol Educ Program; 2013; 2013():109-17. PubMed ID: 24319171
[TBL] [Abstract][Full Text] [Related]
18. MALT lymphomas: pathogenesis can drive treatment.
Bertoni F; Coiffier B; Salles G; Stathis A; Traverse-Glehen A; Thieblemont C; Zucca E
Oncology (Williston Park); 2011 Nov; 25(12):1134-42, 1147. PubMed ID: 22229204
[TBL] [Abstract][Full Text] [Related]
19. Gastric MALT-Lymphoma: more than Helicobacter Pylori.
Van de Vyver G; Vandamme T; Steger PH; Staessen D
Acta Gastroenterol Belg; 2021; 84(4):657-659. PubMed ID: 34965047
[TBL] [Abstract][Full Text] [Related]
20. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
